KONG GARHENG reported 1 transaction at XERIS BIOPHARMA HOLDINGS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/1/2024ACC: 0001867096-24-000041
Director
Since Oct 2021
+6.47K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
6.47K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6.47K
Price / share
—
Trade value
—
% of position
6.0%
3/15/2024
107.67K→114.14K
Total
Net shares
+6.47K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/15/2024 | J · J | +6.47K | — | — | 6.0% | 107.67K | 114.14K |
| Total | +6.47K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported